Ashley Otter

7.7k total citations
21 papers, 277 citations indexed

About

Ashley Otter is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ashley Otter has authored 21 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Ashley Otter's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers) and Poxvirus research and outbreaks (6 papers). Ashley Otter is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (7 papers) and Poxvirus research and outbreaks (6 papers). Ashley Otter collaborates with scholars based in United Kingdom, Netherlands and Canada. Ashley Otter's co-authors include Helen Parry, Christine Stephens, Jianmin Zuo, Rachel Bruton, Paul Moss, Kevin Brown, Gayatri Amirthalingam, Bassam Hallis, Christopher Bentley and Sian Faustini and has published in prestigious journals such as Nature Communications, FEMS Microbiology Reviews and Vaccine.

In The Last Decade

Ashley Otter

16 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Otter United Kingdom 8 207 62 48 36 35 21 277
Sara Caldrer Italy 8 168 0.8× 44 0.7× 47 1.0× 40 1.1× 23 0.7× 19 355
Alex Richter United Kingdom 6 278 1.3× 63 1.0× 29 0.6× 14 0.4× 15 0.4× 9 327
Cecilie Bo Hansen Denmark 13 297 1.4× 19 0.3× 96 2.0× 74 2.1× 22 0.6× 37 409
David X. Lee United States 5 272 1.3× 17 0.3× 49 1.0× 28 0.8× 47 1.3× 7 287
Elli Rosenberg Israel 8 159 0.8× 28 0.5× 38 0.8× 21 0.6× 11 0.3× 17 248
Helen E. Kent Australia 8 291 1.4× 29 0.5× 104 2.2× 70 1.9× 27 0.8× 12 386
Francesca L. Mordant Australia 10 382 1.8× 31 0.5× 107 2.2× 72 2.0× 32 0.9× 19 476
Martin Qui Singapore 6 299 1.4× 27 0.4× 95 2.0× 38 1.1× 35 1.0× 7 349
Maximilian Koblischke Austria 8 231 1.1× 29 0.5× 59 1.2× 61 1.7× 5 0.1× 10 284
Danijela Miljanovic Serbia 10 174 0.8× 44 0.7× 33 0.7× 24 0.7× 9 0.3× 20 334

Countries citing papers authored by Ashley Otter

Since Specialization
Citations

This map shows the geographic impact of Ashley Otter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Otter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Otter more than expected).

Fields of papers citing papers by Ashley Otter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Otter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Otter. The network helps show where Ashley Otter may publish in the future.

Co-authorship network of co-authors of Ashley Otter

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Otter. A scholar is included among the top collaborators of Ashley Otter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Otter. Ashley Otter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaeck, Luca M., Pacifique Ndishimye, Jean Claude Udahemuka, et al.. (2025). Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC. Nature Communications. 16(1). 7056–7056.
2.
Otter, Ashley, et al.. (2025). Mpox: current knowledge and understanding—a scoping review. FEMS Microbiology Reviews. 49. 2 indexed citations
3.
Jones, Scott, Bethany Hicks, D. R. C. Bailey, et al.. (2025). Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study. The Lancet Microbe. 6(4). 100987–100987. 4 indexed citations
4.
Hettiarachchi, Nipunadi, Ashley Otter, Angela Dunne, et al.. (2025). Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UK. BMC Medical Research Methodology. 25(1). 165–165.
5.
Faustini, Sian, Scott Jones, Christopher Green, et al.. (2025). Developing accessible and affordable tests to support mpox immunosurveillance and vaccine studies. Emerging Microbes & Infections. 14(1). 2576581–2576581.
6.
Hicks, Bethany, Scott Jones, D. R. C. Bailey, et al.. (2024). Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity Orthopoxviruses. Vaccine. 42(26). 126453–126453. 2 indexed citations
7.
Otter, Ashley, Christel A.L. de Raaff, Rosaline van den Berg, et al.. (2024). Acute pilonidal abscess: Prospective nationwide audit in the Netherlands. Colorectal Disease. 27(1). 1 indexed citations
8.
9.
Altmann, Daniel M., Catherine J. Reynolds, George Joy, et al.. (2023). Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity. Nature Communications. 14(1). 5139–5139. 20 indexed citations
10.
Atti, Ana, Ferdinando Insalata, Edward J Carr, et al.. (2023). Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study. Journal of Infection. 87(5). 420–427. 5 indexed citations
11.
Parry, Helen, Rachel Bruton, Christine Stephens, et al.. (2022). Extended interval BNT162b2 vaccination enhances peak antibody generation. npj Vaccines. 7(1). 14–14. 59 indexed citations
12.
Harvala, Heli, Dung Nguyen, Peter Simmonds, et al.. (2022). Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization. Transfusion. 62(7). 1347–1354. 10 indexed citations
13.
Parry, Helen, Graham McIlroy, Rachel Bruton, et al.. (2021). Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia. Blood Cancer Journal. 11(7). 136–136. 74 indexed citations
14.
Parry, Helen, Rachel Bruton, Christine Stephens, et al.. (2021). Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people. Immunity & Ageing. 18(1). 34–34. 38 indexed citations
15.
Parry, Helen, Rachel Bruton, Gokhan Tut, et al.. (2021). Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis. The Lancet Healthy Longevity. 2(9). e554–e560. 30 indexed citations
16.
Whitaker, Heather, Suzanne Elgohari, Cathy Rowe, et al.. (2021). Impact of COVID-19 Vaccination Program on Seroprevalence in Blood Donors in England, 2021. SSRN Electronic Journal. 1 indexed citations
17.
Parry, Helen, Graham McIlroy, Rachel Bruton, et al.. (2021). Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia. SSRN Electronic Journal. 4 indexed citations
18.
Weiser, Rebecca, Ashley Otter, Brian V. Jones, et al.. (2020). A Novel Inducible Prophage from Burkholderia vietnamiensis G4 Is Widely Distributed across the Species and Has Lytic Activity against Pathogenic Burkholderia. Viruses. 12(6). 601–601. 9 indexed citations
19.
20.
Wilson, Clare & Ashley Otter. (1986). Drug points: Fixed drug eruption associated with mefenamic acid. BMJ. 293(6556). 1243–1243. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Caldrer Breakdown of academic impact, for papers by Alex Richter Breakdown of academic impact, for papers by Cecilie Bo Hansen Breakdown of academic impact, for papers by David X. Lee Breakdown of academic impact, for papers by Elli Rosenberg Breakdown of academic impact, for papers by Helen E. Kent Breakdown of academic impact, for papers by Francesca L. Mordant Breakdown of academic impact, for papers by Martin Qui Breakdown of academic impact, for papers by Maximilian Koblischke Breakdown of academic impact, for papers by Danijela Miljanovic
Rankless by CCL
2026